Hemobilia patients presents with GI bleeding and elevated liver biochemical tests. The diagnosis is confirmed by:
**Core Concept**
Hemobilia is a clinical condition characterized by the presence of blood in the bile or bile ducts, often resulting from trauma, iatrogenic causes, or underlying liver pathology. The diagnosis of hemobilia typically involves imaging studies to visualize the bleeding site and confirm the presence of blood in the biliary tree.
**Why the Correct Answer is Right**
The correct answer involves the use of endoscopic retrograde cholangiopancreatography (ERCP), a minimally invasive imaging technique that combines endoscopy and fluoroscopy to visualize the biliary and pancreatic ducts. During ERCP, a contrast agent is injected into the biliary tree, and X-rays are taken to visualize the ducts and identify any bleeding sites. This procedure allows for both diagnosis and potential therapeutic intervention, such as embolization or stent placement.
**Why Each Wrong Option is Incorrect**
**Option A:** Angiography may be useful in identifying the bleeding site, but it is not the primary diagnostic modality for hemobilia, which involves the biliary tree rather than the arterial system.
**Option B:** Ultrasound may show indirect signs of hemobilia, such as bile duct dilation or ascites, but it is not specific for diagnosing hemobilia.
**Option C:** CT scan may be useful in identifying complications of hemobilia, such as bile duct stones or strictures, but it is not the best diagnostic tool for confirming hemobilia.
**Clinical Pearl / High-Yield Fact**
ERCP is a valuable tool in the diagnosis and management of hemobilia, but it carries a higher risk of complications compared to other imaging modalities. A thorough understanding of the indications and contraindications for ERCP is essential for optimal patient care.
**Correct Answer: C. ERCP**